Report
Valens Research

REGI - Valens Credit Report - 2021 10 15

Credit markets are materially overstating REGI's credit risk with a YTW of 4.988%, relative to an Intrinsic YTW of 2.618% and an Intrinsic CDS of 123bps. Meanwhile, Moody's is grossly overstating the firm's fundamental credit risk, with its highly speculative B1 credit rating nine notches lower than Valens' IG3+ (A1) credit rating.

Incentives Dictate Behavior™ analysis highlights mixed signals for creditors. Specifically, REGI's compensation framework should focus management on margin expansion and revenue growth, which could lead to Uniform ROA expansion and increased cash flow generation. Additionally, members of management are material holders of REGI equity relative to their annual compensation, indicating they may be well-aligned with shareholders for long-term value creation. Furthermore, management has low change-in-control compensation relative to their average annual compensation, indicating they may not be incentivized to accept a takeover or pursue a sale of the company, reducing event risk.

Earnings Call Forensics™ of the firm's Q2 2021 earnings call (8/5) highlights that management is confident their customers want to demonstrate to consumers that they are decarbonizing. They are also confident many COVID-related headwinds have faded and that their biodiesel production facilities operate with used cooking oils that get double credit in the European market.
Underlying
Renewable Energy Group Inc.

Renewable Energy Group is a biofuels producer with a nationwide distribution and logistics system. The company participates in each aspect of biomass-based diesel production, from acquiring feedstock, managing construction and operating biomass-based diesel production facilities, to marketing, selling and distributing biomass-based diesel and its co-products. To do this, the company utilizes this nationwide production, distribution and logistics system to focus on converting natural fats, oils and greases into biofuels. The company owns and operates a network of biorefineries, which are located in the United States and Germany.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch